Manifestations of psychopathological symptoms in substance abuse during the COVID-19 pandemic

Manifestations of psychopathological symptoms in substance abuse during the COVID-19 pandemic

 

Authors

 

I.I. Sheremetyeva

Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation

A.E. Stroganov

Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation

S.V. Dokenova

Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation

A.V. Plotnikov

Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation

E.O. Kuleshova

Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation

S.S. Kharchenko

Clinical Treatment and Rehabilitation Center “Health Territory”, Barnaul, Russian Federation

 

https://doi.org/10.26617/1810-3111-2023-2(119)-34-41

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2023; 2 (119):  34-41.

 

Abstract

Background. The COVID-19 pandemic has negatively impacted the mental health and psychological well-being of people. Restrictive measures of a medical and social nature, aimed at counteracting the spread of COVID-19, have changed the usual way of life, led to adjustment disorders and mental disorders. The most susceptible category to the influence of the stressful pandemic factor turned out to be people who use psychoactive substances (PAS). According to WHO, since the start of the pandemic, the use of telemedicine and psychological crisis assistance has increased in the provision of mental health services and the treatment of substance dependence. Objective: to assess the level of influence of stress factors on the formation of psychopathological symptoms in patients with substance dependence syndrome during the COVID-19 pandemic, who underwent inpatient treatment at the Altai Regional Narcological Dispensary in 2021-2022. Material and Methods. The study was carried out at the Department of Psychiatry, Medical Psychology and Narcology with the APE course of the Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of Russia. Examination of patients on the basis of voluntary informed consent for participation was carried out on the basis of the Altai Regional Narcological Dispensary. From the total sample (n=302), two groups were formed: the main group (n=196) - patients aged 20-67 years with diagnosed substance dependence, the control group (n=106) - patients of matched age without diagnosis of a addiction disease. In the main group, the diagnosis “Mental and behavioral disorders due to the alcohol use” prevailed (n=159, 81.1%). Dependence syndrome” (F10.2), less often (n=19, 9.7% and n=18, 9.2%) “Mental and behavioral disorders due to the use of opioids. Dependence syndrome” (F11.2) and “Mental and behavioral disorders due to the use of other psychostimulants.” Dependency syndrome" (F15.2). Clinical and psychological research was carried out using the scales for diagnosing anxiety and depression by A. Beck and the Mississippi scale for post-traumatic stress disorder, civilian version. For a multidimensional assessment of the level of psychopathological symptoms, a questionnaire for the severity of psychopathological symptoms was used - Symptom Checklist-90-Revised (SCL-90-R) in an adapted version (Tarabrina N.V., 2000). Calculations were made using data processing software packages Microsoft Office Excel 2013, EpiInfo 7.2. Conclusion. The results of the study show that during the pandemic, regardless of the use of PAS and the presence of PAS dependence syndrome in different contingents of the population, there is a susceptibility to infection with coronavirus infection and the manifestation of psychopathological disorders in the form of symptoms of depression, anxiety, post-traumatic stress disorder, and distress. Further research may be useful in optimizing the quality of treatment and rehabilitation measures provided for patients with substance dependence syndrome.

 

Keywords: new coronavirus infection, addiction syndrome, mental disorders, symptomatic distress.

 

Article (pdf)

 

Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Sheremetyeva I.I., Stroganov A.E., Dokenova S.V., Plotnikov A.V., Kuleshova E.O., Kharchenko S.S. Manifestations of psychopathological symptoms in substance abuse during the COVID-19 pandemic. Siberian Herald of Psychiatry and Addiction Psychiatry. 2023; 2(119): 34-41. https://doi.org/10.26617/1810-3111-2023-2(119)-34-41.

REFERENCES

  1. KislitsynaOA. Long-term negative effects of the COVID-19 pandemic on public health. Social Aspects of Public Health. Electronic scientific journal. 2021;67(4). DOI: 10.21045/2071-5021-2021-67-4-2 (in Russian).
  2. Sheremetyeva II, Stroganov AE, Trunova YuA, Plotnikov AV, Kuleshova EO, Subbotin EA. Clinical and dynamic features of the course of non-psychotic mental disorders in people who have had COVID-19. Bulletin of Medical Science. 2022;28(4):20-26. DOI: 10.31684/25418475-2022-4-20(in Russian).
  3. Sorokin MYu. Affective and cognitive symptoms in COVID-19 survivors: implications for organization of psychiatric services in the post pandemic and within pandemic period. Bulletin of Medical Science. 2022;27(3): 117-127. doi: 10.31684/25418475_2022_3_117(in Russian).
  4. Mosolov SN. Mental health problems in the COVID 19 pandemic. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(5):7-15. doi:10.17116/jnevro20201200517(in Russian).
  5. Pilipovich AA. Peculiarities of management of patients with neurodegenerative diseases in the COVID-19 pandemic. Russian Medical Journal. 2021;5:24-29 (in Russian).
  6. Stoyanova IYa, Ivanova AA, Smirnova NS, Lebedeva VF, Rudenko LS, Magdenko OV, Bokhan NA. Mental disorders developing in the crisis-extremal situation of the coronavirus pandemic: focal problems and features of psychological-psychotherapeutic counseling. Siberian Herald of Psychiatry and Addiction Psychiatry. 2021;1(110):71–77. https://doi.org/10.26617/ 1810-31112021-1(110)-71-77 (in Russian).
  7. Sheremetyeva II, Plotnikov AV, Dokenova SV. Psychogenic disorders in persons with psychoactive substance dependence syndrome caused by an unfavorable epidemiological situation in connection with the spread of a new coronavirus infection. Siberian Herald of Psychiatry and Addiction Psychiatry. 2021; 4(113): 71-78. https://doi.org/10.26617/1810-3111-2021-4(113)-71-78(in Russian).
  8. Stowe MJ, Calvey T, Scheibein F, Arya S, Saad NA, Shirasaka T, Dannatt L, Ghosh A, Yee A, Ratta-Apha W, Vadivel R, Siste K, Shah B, Ramalho R, Narasimha VL, Delic M, Peyron E, Onoria JLG, Pant SB, Boujraf S, Grandinetti P, Morgan N. Access to healthcare and harm reduction services during the covid-19 pandemic for people who use drugs. J Addict Med. 2020 Dec;14(6):e287-e289. doi: 10.1097/ADM.0000000000000753. PMID: 33009167.
  9. Dunlop A, Lokuge B, Masters D, Sequeira M, Saul p, Dunlop G, Ryan J, Hall M, Ezard N, Haber P, Lintzeris N, Maher L. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020 May 6;17(1):26. doi: 10.1186/s12954-020-00370-7. PMID: 32375887; PMCID: PMC7201394.
  10. Boiko OM, Medvedeva TI, Enikolopov SN, Vorontsova OYu, Kazmina OYu. The psychological state of people during the COVID-19 pandemic and the target of psychological work. Psychological Research: Electronic Scientific Journal. 2020;13(70):1-10 (in Russian).
  11. Sheremetyeva II, Plotnikov AV, Dokenova SV, Moldagaliev TM. Impact of the novel coronavirus pandemic on the mental state of people with drug dependence syndrome. Bulletin of Medical Science. 2022;1(25): 83-87. doi: https://doi.org/10. 31684/25418475_2022_1_83(in Russian).
  12. Enikolopov SN, BoikoOM, Medvedeva TI, Vorontsova OYu, Kazmina OYu. Dynamics of psychological reactions at the initial stage of the COVID-19 pandemic. Electronic resource. Psychological and Pedagogical Research. 2020;12(2): 108-126. doi:10.17759/psyedu.2020120207 (in Russian).
  13. Shamsieva SR, Mollaeva NR. Changing drinking behavior during the COVID-19 pandemic. Bulletin of Medical Science. 2022;4(28): 133-142 DOI:10.31684/25418475-2022-4-133(in Russian).
  14. DeJong CAJ, DeJong Verhagen JG, Pols R, Verbrugge CAG, Baldacchino A. Psychological impact of the acute covid-19 period on patients with substance use disorders: we are all in this together. Basic Clin Neurosci. 2020 Mar-Apr;11(2):207-216. doi: 10.32598/bcn.11.covid19.2543.1. Epub 2020 Apr 28. PMID: 32855780; PMCID: PMC7368105.
  15. Kekelidze ZI, Chekhonin VP. Critical conditions in psychiatry (clinical and immune-chemical aspects). Moscow: V.P. Serbsky State Scientific Center for Social and Forensic Psychiatry, 1997:362 (in Russian).
  16. Alexandrovsky YuA, Chekhonin VP. Clinical immunology of borderline mental disorders. Moscow: Publishing House GEOTAR-Media, 2005:249 (in Russian).